Update shared on09 Sep 2025
Fair value Increased 1.75%ALS’s marginally lower future P/E signals a slight improvement in valuation sentiment, while revenue growth expectations remain steady, resulting in a modest price target increase from A$17.77 to A$18.08.
What's in the News
- ALS Limited is actively seeking acquisitions but emphasizes a disciplined capital allocation approach, prioritizing acquisitions that meet return hurdles over volume-based targets.
- The company maintains a focus on achieving mid- to high single-digit organic revenue growth in the medium to long term.
- ALS Limited recently hosted an Analyst/Investor Day.
- The company completed a follow-on equity offering, raising approximately AUD 22.57 million through the issuance of 1,367,350 ordinary shares at AUD 16.51 each.
Valuation Changes
Summary of Valuation Changes for ALS
- The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from A$17.77 to A$18.08.
- The Future P/E for ALS has fallen slightly from 25.09x to 24.52x.
- The Consensus Revenue Growth forecasts for ALS remained effectively unchanged, moving only marginally from 6.8% per annum to 6.7% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.